Design to come?

WP_Post Object
(
    [ID] => 2470
    [post_author] => 3
    [post_date] => 2025-01-25 14:05:41
    [post_date_gmt] => 2025-01-25 19:05:41
    [post_content] => 
    [post_title] => Drug Monitoring Committee Authorizes Continuation of Intensity Therapeutics' Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") Following Periodic Review
    [post_excerpt] => 
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => drug-monitoring-committee-authorizes-continuation-of-intensity-therapeutics-ongoing-global-randomized-phase-3-sarcoma-trial-invincible-3-study-following-periodic-review
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2025-02-25 14:06:15
    [post_modified_gmt] => 2025-02-25 19:06:15
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://vcapital.com/?post_type=news&p=2470
    [menu_order] => 0
    [post_type] => news
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
)